glp-1 receptor agonists glp-1_analogs [TUSOM GLP-1 Agonists - FAQ —
Description
If future research confirms these findings, treatment algorithms could eventually shift toward risk-based rather than weight-based prescribing
Figure 2 Pharmacokinetics The pharmacokinetics in healthy volunteers and patients with T2D are comparable (57)
MC4R: melanocortin-4receptor
Int J Mol Sci 25
Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects
If using allulose to reduce overall sugar intake, this dietary modification may contribute to improved glycaemic control, but medication adjustments should only be made under medical supervision
